SomaSignal Informed Medical Management SSCVD for Type 2 Diabetes

Phase-Based Progress Estimates
1
Effectiveness
1
Safety
Emory Hospital Midtown, Atlanta, GAType 2 DiabetesSomaSignal Informed Medical Management SSCVD - DiagnosticTest
Eligibility
18+
All Sexes
What conditions do you have?
Select

Study Summary

This trial found that the use of a 27-protein model, encompassing ten biological systems, was able to accurately predict who would benefit from a novel glycemia-lowering therapy.

Eligible Conditions
  • Type 2 Diabetes

Treatment Effectiveness

Effectiveness Progress

1 of 3

Similar Trials

1
Caloric Restriction
1
Early Total Caloric Intake
1
SomaSignal Test Results

Study Objectives

1 Primary · 13 Secondary · Reporting Duration: At 6 months

At 6 months
Physician Experience Questionnaire
Baseline and 6 months
Change in medication possession ratio
Changes in CVD risk factors measured by Body Mass Index (BMI)
Changes in CVD risk factors measured by weight
Changes in CVD risk factors measured using laboratory assessments of glucose
High Density Lipoproteins
Changes in CVD risk factors measured using laboratory assessments of low-density lipoprotein (LDL)
Changes in CVD risk factors measured using laboratory assessments of the Glycated Hemoglobin Test (HbA1C)
Changes in CVD risk factors measured using laboratory assessments of triglycerides (TG)
Tobacco
Changes in CVD risk factors measuring dietary habits
Changes in CVD risk factors measuring physical activity
Changes in prescriptions of participants with type 2 diabetes (T2D) in concordance with SSCVD results over a 6-month period
Changes in the SSCVD results

Trial Safety

Safety Progress

1 of 3

Similar Trials

2
Caloric Restriction
1
Early Total Caloric Intake
1
SomaSignal Test Results

Trial Design

2 Treatment Groups

Standard of Care (Uninformed Arm)
1 of 2
SomaSignal Informed Medical Management SSCVD
1 of 2

Active Control

Experimental Treatment

450 Total Participants · 2 Treatment Groups

Primary Treatment: SomaSignal Informed Medical Management SSCVD · No Placebo Group · N/A

SomaSignal Informed Medical Management SSCVD
DiagnosticTest
Experimental Group · 1 Intervention: SomaSignal Informed Medical Management SSCVD · Intervention Types: DiagnosticTest
Standard of Care (Uninformed Arm)
Other
ActiveComparator Group · 1 Intervention: Standard of Care · Intervention Types: Other

Trial Logistics

Trial Timeline

Screening: ~3 weeks
Treatment: Varies
Reporting: at 6 months

Who is running the clinical trial?

SomaLogic, Inc.Industry Sponsor
6 Previous Clinical Trials
1,645 Total Patients Enrolled
Emory UniversityLead Sponsor
1,523 Previous Clinical Trials
2,713,069 Total Patients Enrolled
Arshed Quyyumi, MDPrincipal InvestigatorEmory University
11 Previous Clinical Trials
2,286 Total Patients Enrolled

Eligibility Criteria

Age 18+ · All Participants · 4 Total Inclusion Criteria

Mark “Yes” if the following statements are true for you:
You must be eligible to take one of the following types of medications: SGLT2i, PCSK9i, or GLP-1 RA. If you are currently taking any of these medications, you will not be eligible to participate unless you are only taking PCSK9i.
References

Frequently Asked Questions

Are there any current opportunities to take part in this research?

"According to official records listed on clinicaltrials.gov, this medical trail is currently recruiting individuals for participation. The trial was originally posted on February 3rd 2022 and the most recent update was made on the 15th of that same month." - Anonymous Online Contributor

Unverified Answer

How many volunteers are taking part in this experiment?

"Affirmative. According to the documentation hosted on clinicaltrials.gov, this medical trial was initially listed on February 3rd 2022, and is actively in pursuit of 450 participants from 5 different centres." - Anonymous Online Contributor

Unverified Answer
Please Note: These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top